Marc R. Parrish, D.O., MBsc, FACOG

Professional Background

Medical School at Kansas City University of Medicine and Biosciences

OBGYN Residency: University of Missouri-Kansas City

Maternal-Fetal Medicine Fellowship: University of Mississippi Medical Center

After my Fellowship, we moved to the Kansas City area and have been here since 2010. I spent three years with a wonderful group of people in private practice at St Luke's Hospital. I was lured back to the Academic World in the summer of 2013. I have been fortunate to work with another great group of people at The University of Kansas Medical Center ever since then.

Clinical and research interests: I have many but my strongest passion is toward preeclampsia and other hypertensive disorders of pregnancy

Things that keep me sane: My family (at times contributes to my insanity), travel (going crazy right now not being able to travel!), trying different beers, wine and bourbon and fishing!

• BS, Biology, Southwestern College
• DO, Doctor of Osteopathy, Kansas City Univ of Med&BioSci
• Residency, Obstetrics and Gynecology, University of Missouri-Kansas City, Kansas City, MO
• Clinical Fellowship, Maternal-Fetal Medicine, University of Mississippi Medical Center, Jackson , MS

• Kansas Medical License , Kansas State Board of Healing Arts
• Maternal-Fetal Medicine, American Board of Obstetrics and Gynecology
• Missouri Medical License, Missouri State Board of Healing Arts
• Obstetrics and Gynecology, American Board of Obstetrics and Gynecology

• Association of Professors of Gynecology and Obstetrics, Member, 2019 - Present
• Kansas City Gynecological Society, Treasurer, 2019 - 2021
• American College of Obstetricians and Gynecologists, Fellow, 2009 - Present
• American Institute of Ultrasound in Medicine, Member, 2007 - Present
• Central Association of Obstetricians and Gynecologists, Member, 2007 - Present
• Society of Maternal Fetal Medicine, Member, 2005 - Present

---

Research

Overview

During my fellowship, my research focus aimed to identify various pathologic mechanisms that played integral roles in the manifestation of preeclampsia. Since that time I have carried this passion into pursuing clinically related preeclampsia projects. Our Fellows and our Division have teamed up with the Institute for Reproduction and Perinatal Research through the University of Kansas Medical Center. Our collaboration continues to contribute toward a better understanding of placental derived disease processes, including preeclampsia, that result in adverse maternal, fetal and newborn outcomes. It is our collective aim to use this knowledge to improve pregnancy outcomes.

Fortunately, my colleagues have a variety of other research interests that I have gotten to participate in. These opportunities continue to broaden my knowledge of many disease processes that can result in significant maternal morbidity.

• Parrish, MR. 2016. Cardiopulmonary Disorders associated with HELLP Syndrome
• Parrish, MR, Morrison, JC. 2016. Sickle Cell Disease
• Lamarca, B, Parrish, MR, Wallace, K. 2012. Agonistic autoantibodies to the angiotensin II Type I receptor cause pathophysiologic characteristics of preeclampsia. . Gend Med, 9, 139-146
• Winchester, M, Platzbecker, R, McMahon, M, Parrish, MR. 2019. Eculizumab Maintenance and the Prevention of Atypical Hemolytic Uremic Syndrome Relapse During Pregnancy: A Case Report. J Med Cases, 10 (12), 343-344
• Martin, Jr, JN, Owens, MY, Thigpen, B, Parrish, MR, Keiser, S, Wallace, K. 2012. Management of late preterm pregnancy complicated by mild preeclampsia: A prospective randomized trial. . Pregnancy Hypertension , 3, 180
• Parrish, MR, Martin, Jr, JN, Lamarca, B, Ellis, B, Parrish, S, Owens, MY, May, W. 2013. Randomized, Placebo Controlled, Double Blind Trial Evaluating Early Pregnancy Phytonutrient Supplementation in the Prevention of Preeclampsia. . Journal of Perinatology, 33, 593-599
• Martin, Jr, JN, Owens, MY, Keiser, S, Parrish, MR, Tam Tam, K, Brewer, J, Cushman, J, May, W. 2012. Standardized Treatment of HELLP Syndrome Using the Mississippi Protocol: No Maternal Death, Stroke or Liver Rupture in 190 Patients. . Hypertension in Pregnancy , 31 (1), 79-90